Activated human neonatal CD8+ T cells are subject to immunomodulation by direct TLR2 or TLR5 stimulation.
about
Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor LigandsNeonatal mucosal immunization with a non-living, non-genetically modified Lactococcus lactis vaccine carrier induces systemic and local Th1-type immunity and protects against lethal bacterial infection.NOD1 cooperates with TLR2 to enhance T cell receptor-mediated activation in CD8 T cells.CD8+ cells enhance resistance to pulmonary serotype 3 Streptococcus pneumoniae infection in miceMycobacterium tuberculosis lipoproteins directly regulate human memory CD4(+) T cell activation via Toll-like receptors 1 and 2.Engagement of TLR2 does not reverse the suppressor function of mouse regulatory T cells, but promotes their survivalDirect Toll-Like Receptor 8 signaling increases the functional avidity of human CD8+ T lymphocytes generated for adoptive T cell therapy strategies.TLR5 Ligand-Secreting T Cells Reshape the Tumor Microenvironment and Enhance Antitumor Activity.Inclusion of Flagellin during Vaccination against Influenza Enhances Recall Responses in Nonhuman Primate Neonates.Adjuvants in the Driver's Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune PotentiatorsActivation of toll-like receptor 2 prevents suppression of T-cell interferon γ production by modulating p38/extracellular signal-regulated kinase pathways following alcohol and burn injury.TLR agonists: our best frenemy in cancer immunotherapyFlagellin as an adjuvant: cellular mechanisms and potential.Direct TLR-2 Costimulation Unmasks the Proinflammatory Potential of Neonatal CD4+ T Cells.Prior TLR5 induction in human T cells results in a transient potentiation of subsequent TCR-induced cytokine production.Distinct signaling pathways regulate TLR2 co-stimulatory function in human T cells.Rapid CD8+ Function Is Critical for Protection of Neonatal Mice from an Extracellular Bacterial Enteropathogen.Modulation of immune responses through direct activation of Toll-like receptors to T cells.Tumor necrosis factor receptor/tumor necrosis factor family members in antiviral CD8 T-cell immunity.Immune adjuvants in early life: targeting the innate immune system to overcome impaired adaptive response.Insights into the role of Toll-like receptors in modulation of T cell responses.Mechanisms of action of adjuvantsVaccines against respiratory viral pathogens for use in neonates: opportunities and challenges.Bacterial flagellin-a potent immunomodulatory agent.Biological Response Modifier in Cancer Immunotherapy.A Novel R848-Conjugated Inactivated Influenza Virus Vaccine Is Efficacious and Safe in a Neonate Nonhuman Primate Model.Adjuvanting an inactivated influenza vaccine with flagellin improves the function and quantity of the long-term antibody response in a nonhuman primate neonate model.An R848 adjuvanted influenza vaccine promotes early activation of B cells in the draining lymph node of nonhuman primate neonates.Potent induction of IFN-γ production from cord blood NK cells by the stimulation with single-stranded RNA.T-cell receptor activation of human CD4(+) T cells shifts the innate TLR response from CXCL8(hi) IFN-γ(null) to CXCL8(lo) IFN-γ(hi).
P2860
Q28972540-2E57B001-CBBA-4E5E-87FC-B78E671240CDQ33824760-06100815-A064-4010-92CF-69BA047E9C0AQ34359613-DC089774-B71E-4F57-AF3B-F6A29855CBCAQ34444975-1CCE9A79-7117-4F8F-9115-346B8A846CB8Q34529474-1BC344FE-7C5C-42D6-80C7-D5180C450C74Q34611787-3E2ED271-BD2E-4782-A4B2-14B8C8547424Q35285757-29542BC1-9318-4E68-B7D3-562BFDADE3A6Q35612358-5CCEAFAB-E5BB-480E-9A64-2F0544D0B349Q35758568-5672ED1B-1E5C-4B80-901D-DA628FF17CD7Q35826747-9E2D9EC9-1794-43A8-807D-1DB681CA8FA3Q36283414-CCFBCF20-3A8F-4BEF-A19C-EEB85A6181F5Q36850457-D7C12105-F7CD-4008-BD70-0EF2342BDBD3Q37130379-608D9D90-C285-4154-9C09-3089E89D8968Q37255692-631B0BEE-4B59-4931-AD20-13DA565E9564Q37353574-50A7C120-E928-4A4E-BC90-42D7E0C9D468Q37444593-1CB3ED04-69E0-49A0-A5D9-6A330FFF3E98Q37571693-9192ABA0-B5E1-4D91-8F13-AB41D3CBC4E1Q37686558-09FB8827-C19C-410B-BBD6-C61D8561D860Q37727208-5C4E1E0F-EBC4-4A20-809F-0D4C6CE10FA5Q37773306-39B08194-2400-49D3-99CE-97C12C22F5B2Q37777344-0BB0F7FE-9655-4400-9FDD-AD72F6B08F43Q38110539-C0DB1A95-E114-41C4-8D6A-D6EC4526756DQ38269845-05185337-571C-4709-9DEE-8B0B5A6F051DQ38634734-E7D3C727-7703-4C8D-9BA6-779F9B0B2FDFQ38848213-FA90EF57-EE6F-4917-A3D7-B64476026FD3Q39698048-2D0FA6A0-0748-4912-8D9E-CFDF908A5BD4Q40578582-924AFCF1-6439-4B70-B409-5931C59A789AQ41931711-394AADCC-706D-4FFE-A433-37ED9464A981Q44993630-8DE9D294-8F5D-45C3-90B5-6F0EE5DCA0C3Q54257184-33C3CD84-6F06-4BBE-A9F7-04E39F63E319
P2860
Activated human neonatal CD8+ T cells are subject to immunomodulation by direct TLR2 or TLR5 stimulation.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Activated human neonatal CD8+ ...... rect TLR2 or TLR5 stimulation.
@en
type
label
Activated human neonatal CD8+ ...... rect TLR2 or TLR5 stimulation.
@en
prefLabel
Activated human neonatal CD8+ ...... rect TLR2 or TLR5 stimulation.
@en
P1476
Activated human neonatal CD8+ ...... irect TLR2 or TLR5 stimulation
@en
P2093
Denis J Reen
P356
10.4049/JIMMUNOL.182.1.55
P407
P577
2009-01-01T00:00:00Z